These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 18172298)
1. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298 [TBL] [Abstract][Full Text] [Related]
2. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502 [TBL] [Abstract][Full Text] [Related]
3. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer. Winnes M; Lissbrant E; Damber JE; Stenman G Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040 [TBL] [Abstract][Full Text] [Related]
5. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer]. Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766 [TBL] [Abstract][Full Text] [Related]
6. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152 [TBL] [Abstract][Full Text] [Related]
7. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer. Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484 [TBL] [Abstract][Full Text] [Related]
11. ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Tomlins SA; Bjartell A; Chinnaiyan AM; Jenster G; Nam RK; Rubin MA; Schalken JA Eur Urol; 2009 Aug; 56(2):275-86. PubMed ID: 19409690 [TBL] [Abstract][Full Text] [Related]
12. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer. Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504 [TBL] [Abstract][Full Text] [Related]
13. ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples. Miyagi Y; Sasaki T; Fujinami K; Sano J; Senga Y; Miura T; Kameda Y; Sakuma Y; Nakamura Y; Harada M; Tsuchiya E Mod Pathol; 2010 Nov; 23(11):1492-8. PubMed ID: 20693979 [TBL] [Abstract][Full Text] [Related]
14. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. Esgueva R; Perner S; J LaFargue C; Scheble V; Stephan C; Lein M; Fritzsche FR; Dietel M; Kristiansen G; Rubin MA Mod Pathol; 2010 Apr; 23(4):539-46. PubMed ID: 20118910 [TBL] [Abstract][Full Text] [Related]
16. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Demichelis F; Fall K; Perner S; Andrén O; Schmidt F; Setlur SR; Hoshida Y; Mosquera JM; Pawitan Y; Lee C; Adami HO; Mucci LA; Kantoff PW; Andersson SO; Chinnaiyan AM; Johansson JE; Rubin MA Oncogene; 2007 Jul; 26(31):4596-9. PubMed ID: 17237811 [TBL] [Abstract][Full Text] [Related]
17. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. Rajput AB; Miller MA; De Luca A; Boyd N; Leung S; Hurtado-Coll A; Fazli L; Jones EC; Palmer JB; Gleave ME; Cox ME; Huntsman DG J Clin Pathol; 2007 Nov; 60(11):1238-43. PubMed ID: 17259299 [TBL] [Abstract][Full Text] [Related]
18. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Wang J; Cai Y; Ren C; Ittmann M Cancer Res; 2006 Sep; 66(17):8347-51. PubMed ID: 16951141 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Laxman B; Tomlins SA; Mehra R; Morris DS; Wang L; Helgeson BE; Shah RB; Rubin MA; Wei JT; Chinnaiyan AM Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688 [TBL] [Abstract][Full Text] [Related]
20. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]